COVID-19

COVID-19 could cost UK £7 billion a year without autumn vaccinations

A new OHE model shows that stopping annual autumn COVID-19 vaccinations could cost the UK economy £7 billion each year.

Tackling ‘care phobia’ – key to health & wealth in later life

Mary Bright, Head of Social Affairs and Age Special Adviser at Phoenix Group, explains why tackling ‘care phobia’ is the key to unlocking health and wealth in later life.

Test & Trace: A permanent fixture in the new normal?

Now that we are living in a country that is largely free from Coronavirus restrictions, will Test & Trace remain part of our new normal? Rhian Gorecki, Research Manager at Walnut UNLIMITED explores here.

COVID and a year of telehealth

Rowan Pritchard Jones, Medical Director at St Helens and Knowsley Teaching Hospitals NHS Trust, discusses how telehealth has helped the hospital support its patients during COVID and beyond.

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Impact of COVID-19 in African countries

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.

Interoperability & driving the healthcare digital rebound

Mike Smith, Director Large Enterprise & Public Sector at Virgin Media 02 Business, focuses our thoughts on achieving interoperability and driving the digital rebound in healthcare.

Oral health & optimal dental care in Europe

Dr Reddy, Dentist at Harley Street Specialist Hospital, explains why it’s important to promote oral health and provide optimal dental care in Europe today.

Open Science for global challenges & restoring the ethos of science

The EUA illustrates how the COVID-19 pandemic revealed the power of sharing research outputs in addressing global crises.

Optimising infection control post-pandemic

Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.

COVID-19: Antibody levels for the double-jabbed are waning

Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.

Public health response to dementia

Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.

A look at brain tumour diagnosis & therapy

Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.

Double vaccination reduces risk of Long COVID by 49%

Double vaccinated adults are 49% less likely to have Long COVID if they were to contract COVID-19, according to a new study.

More must be done to tackle diabetes

Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

Immunocompromised patients show low immune response after second vaccine

According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders